The hypothesis that increased dietary protein augments distal nephron acidification through endothelin-mediated increased aldosterone activity was tested. Munich-Wistar rats were studied after 3 wk of diets with 50% high protein (HiPro) and 20% control (CON) casein-provided protein, the latter comparable to standard diet. HiPro versus CON rats had higher distal nephron H ؉ secretion by in vivo microperfusion as shown previously. tal nephron acidification (1,2) through endothelindependent mechanisms (3). Dietary intake of acidproducing protein also increases distal nephron acidification (4,5) by mechanisms that are also endothelin dependent (5). In the latter studies, augmented distal nephron acidification was due to an endothelin-mediated increase in both Na ϩ /H ϩ exchange and H ϩ -ATPase activity (5). Endothelin stimulates Na ϩ /H ϩ exchange in vitro (6 -8), but no studies report that endothelin increases in vitro H ϩ -ATPase activity. Consequently, endothelin might stimulate H ϩ -ATPase activity indirectly given the many endocrine alterations induced by a systemic acid challenge, including stimulation of the reninangiotensin-aldosterone axis (9,10). Because increased dietary protein increases serum aldosterone (11), aldosterone increases distal nephron H ϩ -ATPase activity (12), and endothelin infusion increases aldosterone secretion in vivo (13, 14) , the present studies tested the hypothesis that the endothelin-mediated increase in distal nephron H ϩ -ATPase activity induced by acidproducing dietary protein is due to increased aldosterone activity.
D ietary acid as ammonium (NH 4
ϩ ) salts augments distal nephron acidification (1,2) through endothelindependent mechanisms (3) . Dietary intake of acidproducing protein also increases distal nephron acidification (4, 5) by mechanisms that are also endothelin dependent (5) . In the latter studies, augmented distal nephron acidification was due to an endothelin-mediated increase in both Na ϩ /H ϩ exchange and H ϩ -ATPase activity (5) . Endothelin stimulates Na ϩ /H ϩ exchange in vitro (6 -8) , but no studies report that endothelin increases in vitro H ϩ -ATPase activity. Consequently, endothelin might stimulate H ϩ -ATPase activity indirectly given the many endocrine alterations induced by a systemic acid challenge, including stimulation of the reninangiotensin-aldosterone axis (9, 10) . Because increased dietary protein increases serum aldosterone (11), aldosterone increases distal nephron H ϩ -ATPase activity (12) , and endothelin infusion increases aldosterone secretion in vivo (13, 14) , the present studies tested the hypothesis that the endothelin-mediated increase in distal nephron H ϩ -ATPase activity induced by acidproducing dietary protein is due to increased aldosterone activity.
Materials and Methods

Animals and Diet Protocol
Male and female Munich-Wistar rats (Harlan Sprague-Dawley, Houston, TX; 200 to 220 g) ate standard rat chow (Prolab RMH 2500 with 23% protein) for 1 wk, then ate a custom minimum electrolyte diet with protein as purified high-nitrogen casein (ICN Nutritional Biochemicals, Cleveland, OH) for 3 wk. High protein (HiPro) and control (CON) rats ate 50 and 20% protein, respectively. In preliminary studies, similar-weight rats ate 24.6 Ϯ 0.9 and 27.1 Ϯ 1.2 g/d, respectively (n ϭ 4, P ϭ 0.15), so all rats received 24 g/d diet to ensure similar and complete intake. Some ingested bosentan (Actelion, Allschwil, Switzerland), a nonpeptide endothelin A/B receptor antagonist (15) , mixed with study diet (100 mg/kg body wt per d). This oral dose blocks action of pressor doses of intravenous big endothelin-1 (ET-1) for Ͼ24 h (15) . Others ingested spironolactone (400 mg/kg body wt per d) dissolved in olive oil and mixed with diet. This oral dose is in excess of that required for virtually complete mineralocorticoid receptor blockade in vivo (16 
Urine Net Acid and ET-1 Excretion
We measured daily urine net acid excretion (NAE) (17) and ET-1 (3) in a 24-h sample collected as described (5) from eight each of HiPro and CON rats in metabolic cages. We examined the effect of endothelin and aldosterone receptor blockade with bosentan and spironolactone, respectively, on urine NAE in paired and separate groups of eight each (four with and four without drug) of HiPro and CON rats. NAE was the mean for each animal group.
Arterial Blood Parameters
We measured pH, Pco 2 , calculated [HCO 3 ] (IRMA Blood Analysis System, Diametrics Medical, Inc., St. Paul, MN) and total CO 2 (TCO 2 ) by ultrafluorometry (see below) in 1.0 ml of blood from a chronic carotid arterial catheter in eight each of awake, gently restrained, and calm HiPro and CON rats to assess the effects of HiPro on plasma acid-base parameters. We also measured arterial BP through this chronic arterial catheter as done previously (18) .
Micropuncture Protocol
Animals were prepared for micropuncture of accessible distal tubules (19) at weeks 1 and 3. In situ early distal flow rate for HiPro and CON rats was 9.4 Ϯ 0.7 (n ϭ 6) and 6.4 Ϯ 0.4 nl/min (n ϭ 8), respectively. Separate superficial distal nephrons of HiPro and CON rats were each perfused 9 and 6 nl/min with a Hampel pump to approximate respective in situ flow rates. We measured distal tubule transepithelial potential difference to calculate blood-to-lumen HCO 3 permeability (19) . After the micropunctured (left) kidney was weighed, perfused nephron length was determined by measuring the length of a latex cast injected after micropuncture, recovered after acid digestion of the kidney (19 
Identification of H ϩ Transport Mediators of HiPro-Induced Changes in Distal Nephron Acidification
We compared the net decrease in distal nephron H ϩ secretion in response to specific H ϩ transport inhibitors to determine contributions of individual distal nephron H ϩ transporters to differences in overall distal nephron H ϩ secretion in HiPro versus CON rats. The contribution of Na ϩ /H ϩ exchange and H ϩ -ATPase was determined by perfusing with solutions that contained EIPA (10 Ϫ5 M) and bafilomycin (10 Ϫ7 M), respectively, as done previously in our laboratory (22) . Because the rat renal cortex contains the gastric isoform of H ϩ -K ϩ -ATPase (23), we perfused tubules with Sch 28080 (10 Ϫ5 M) to inhibit this transporter (24) and determine whether its activity was increased in HiPro rats. Although the colonic isoform of H ϩ -K ϩ -ATPase has not been identified in the rat renal cortex (25) and its presence has not been induced by dietary NH 4 Cl (25), we additionally perfused distal nephrons with solutions that contained both Sch 28080 (10 Ϫ5 M) and ouabain (10 Ϫ3 M), the latter inhibiting the colonic H ϩ -K ϩ -ATPase isoform (24) . The latter perfusion was done to determine whether HiPro induced and/or increased activity of either the gastric or colonic H ϩ -K ϩ -ATPase isoforms.
Greater inhibitor-induced decrease in H ϩ secretion in HiPro versus CON rats determined increased activity of the H ϩ transporter inhibited by that compound (22) .
Analytical Methods
Immediately after experiment termination, initial and collected perfusate and stellate vessel plasma samples were analyzed for inulin (19) and for TCO 2 using flow-through ultrafluorometry (26) as described previously (27) . All tubule fluid and plasma TCO 2 were measured on the experimental day by comparing fluorescence of a 7-to 8-nl sample aliquot (corrected for a distilled H 2 O blank run with each sample group) with a standard curve as described previously (27) . This technique actually measures TCO 2 , but we refer to this measured value as HCO 3 for simplicity.
Statistical Analyses
Data were expressed as means Ϯ SEM. One to two distal nephron segments were perfused per animal. When two tubules were perfused in an animal, results were meaned to yield a single value for that animal. Group number is number of animals. Paired perfusions of the same tubule were compared using paired t test; otherwise, ANOVA was used for multiple group comparisons. We used the Bonferroni method for multiple comparisons (P Ͻ 0.05) of the same parameter among groups.
Results
Effect of HiPro and Receptor Antagonists on Animal/ Kidney/Tubule Growth
The HiPro protocol increases body and kidney weight as well as the length of the accessible distal tubule (5) . Neither the endothelin A/B receptor antagonist bosentan nor the mineralocorticoid antagonist spironolactone affected animal/kidney weight, tubule length, food intake, or urine output in either group. 
Effect of HiPro on Renal Acidification
HiPro rats have higher urine NAE than CON rats mediated by higher urine NH 4 ϩ and lower HCO 3 excretion with similar excretion of titratable acid (5). Distal nephron net HCO 3 reabsorption was higher in HiPro than CON rats perfused at 6 and 9 nl/min as a result of higher H ϩ secretion and to less extent to lower HCO 3 secretion (5). 
Transport Mediators of Enhanced Distal Nephron Acidification in HiPro Rats
Effect of HiPro on Renal ET-1 and Aldosterone Production
HiPro increases urine ET-1 excretion, ET-1 addition to renal cortical microdialysate, and renal cortical mRNA (5). Figure 2 shows that HiPro compared with CON rats had higher plasma aldosterone (60.9 Ϯ 5.9 versus 42.2 Ϯ 2.4 pg/ml; P ϭ 0.033, ANOVA; n ϭ 8 animals each) and higher urine aldosterone excretion (21.9 Ϯ 3.5 versus 10.5 Ϯ 1.8 ng/d; P ϭ 0.035, ANOVA; n ϭ 8 animals each) in the absence of bosentan. By contrast, plasma aldosterone (51.4 Ϯ 4.9; P ϭ 0.34 versus CON; n ϭ 8 animals) and urine aldosterone excretion (13.0 Ϯ 2.7; P ϭ 0.45 versus CON; n ϭ 8 animals) were not different between bosentan-ingesting HiPro and CON rats, respectively.
Effect of Endothelin and Mineralocorticoid Receptor Blockade on Arterial Blood and Urine Parameters
Bosentan did not affect CON arterial plasma acid-base parameters (data not shown). Plasma TCO 2 , urine net NAE, and MBP were not different in HiPro rats that did compared with did not ingest bosentan (5) . By contrast, CON rats that ingested spironolactone had lower plasma TCO 2 than concurrently studied CON rats that did not ingest spironolactone (22.9 Ϯ 0.6 versus 25.2 Ϯ 0.6 mM; P ϭ 0.017; n ϭ 8 animals each) but similar urine NAE (3569 Ϯ 448 versus 4460 Ϯ 639 M/d; P ϭ 0.27; n ϭ 8 animals each) and MBP (107.8 Ϯ 2.2 versus 110.1 Ϯ 2.2 mmHg; P ϭ 0.74; n ϭ 8 animals each). Similarly, HiPro rats that did compared with concurrently studied HiPro rats that did not ingest spironolactone had lower plasma TCO 2 (20.2 Ϯ 0.8 versus 23.0 Ϯ 0.5 mM; P ϭ 0.02; n ϭ 8 animals each) but similar urine NAE (6210 Ϯ 589 versus 7067 Ϯ 937 M/d; P ϭ 0.45; n ϭ 8 animals each) and MBP (110.7 Ϯ 2.2 versus 111.5 Ϯ 2.4 mmHg; P ϭ 0.81; n ϭ 8 animals each).
Effect of Endothelin and Mineralocorticoid Receptor Blockade on HiPro-Induced Augmented Distal Nephron Acidification
Distal nephron acidification was not different between CON rats that did and did not receive bosentan (5) . Similarly, distal nephron net HCO 3 reabsorption was not different between CON rats that did and did not receive spironolactone whether perfused at 6 nl/min (10.8 Ϯ 1.7 versus 12.9 Ϯ 1.4 pmol/mm per min, respectively; P ϭ 0.36; n ϭ 8 animals each) or 9 nl/min (12.8 Ϯ 1.9 versus 14.9 Ϯ 1.4 pmol/mm per min; P ϭ 0.39; n ϭ 8 animals each). By contrast, HiPro rats that did compared with did not receive bosentan had lower distal tubule net HCO 3 reabsorption that was mediated by lower H ϩ secretion and higher HCO 3 secretion (5) . Similarly, Figure 3 shows that HiPro rats that did compared with did not receive spironolactone had lower distal nephron net HCO 3 reabsorption (26.7 Ϯ 3.0 versus 39.0 Ϯ 3.1 pmol/mm per min; P Ͻ 0.013; n ϭ 8 animals each). Like the decreased distal nephron net HCO 3 reabsorption as a result of bosentan, the decreased distal nephron net HCO 3 reabsorption as a result of spironolactone was mediated by reduced H ϩ secretion (29.2 Ϯ 3.3 versus 42.1 Ϯ 3.8 pmol/mm per min; P Ͻ 0.023; n ϭ 8 animals each). Unlike decreased distal nephron net HCO 3 reabsorption induced by bosentan that was also mediated by increased distal nephron HCO 3 secretion (5), this component of distal nephron net HCO 3 reabsorption was not different in HiPro rats that did compared with did not ingest spironolactone (Ϫ5.4 Ϯ 0.6 versus Ϫ3.9 Ϯ 0.7 pmol/mm per min; P ϭ 0.13; n ϭ 8 animals each).
Effect of Endothelin and Mineralocorticoid Receptor Blockade on Enhanced H ϩ Transporter Activity Induced by HiPro
Net decrease in distal nephron H ϩ secretion was not different in bosentan-ingesting compared with noningesting HiPro rats that were perfused at 9 nl/min with EIPA and bafilomycin, consistent with no additional effect of these inhibitors on Na ϩ /H ϩ exchange and H ϩ -ATPase activity, respectively, in
HiPro rats with endothelin A/B receptor blockade (5) . There was also no difference in the net decrease in H ϩ secretion in bosentan-ingesting compared with noningesting HiPro rats that were perfused with Sch 28080 (5), consistent with no effect of endothelin A/B receptor blockade on H ϩ -K ϩ -ATPase activity in HiPro rats. By contrast, Figure 4 shows that spironolactone-ingesting compared with noningesting HiPro rats had less bafilomycin-induced decrease in distal nephron H ϩ secretion when perfused at 9 nl/min (Ϫ6.5 Ϯ 1.2 versus Ϫ14.5 Ϯ 1.1 pmol/mm per min; P Ͻ 0.001; n ϭ 8 animals each), consistent with spironolactone-induced inhibition of the previously demonstrated augmented H ϩ -ATPase activity of HiPro rats. By contrast, EIPA-induced (Ϫ13.2 Ϯ 1.4 versus Ϫ15.9 Ϯ 1.1 pmol/mm per min; P ϭ 0.15 at 9 nl/min; n ϭ 8 animals each), Sch 28080-induced (Ϫ6.1 Ϯ 0.9 versus Ϫ4.0 Ϯ 0.8 pmol/mm per min; P ϭ 0.10 at 9 nl/min; n ϭ 8 animals each), and Sch 28080 ϩouabain-induced (Ϫ8.9 Ϯ 1.6 versus Ϫ6.6 Ϯ 0.9 pmol/mm per min; P ϭ 0.26 at 9 nl/min; n ϭ 4 animals each) decrease in distal nephron H ϩ secretion was not different in spironolactone-ingesting compared with noningesting HiPro rats, consistent with no spironolactone effect on Na
ATPase activity, respectively, in HiPro rats. 
Discussion
These studies tested the hypothesis that the endothelindependent increase in distal nephron H ϩ -ATPase activity in
HiPro rats (5) ported studies supporting that spironolactone increases endogenous acid production (33) that might have contributed to the decrease in plasma TCO 2 observed in both HiPro and CON animals that ingested spironolactone. The microperfusion studies reported in the present studies nevertheless support that aldosterone-mediated increased H ϩ -ATPase activity contributed to the augmented H ϩ secretion of HiPro animals.
The mechanisms by which dietary acid as NH 4 ϩ salts (3) or as acid-producing dietary protein (4,5) increases renal endothelin production and cell type that is the endothelin source are not clear. Renal microvascular endothelial cells that are exposed to an acid extracellular environment in vivo increase ET-1 release into the culture medium (34) , possibly contributing to increased renal interstitial fluid ET-1 levels in response to dietary acid (3). Nevertheless, renal epithelial cells also make and secrete ET-1 (35) and might also be a source of the augmented renal endothelin. The present studies support that the increased plasma and urine aldosterone associated with HiPro was mediated by endothelin. Similarly, chronic dietary NH 4 Cl increases plasma aldosterone (36) , and endothelin might also mediate the increased plasma aldosterone that occurs in this setting. Endothelin infusion increases aldosterone secretion in rats in vivo (13, 14) , and endothelin is an important paracrine regulator of zona glomerulosa function (37) . In summary, HiPro as purified casein augments distal nephron H ϩ secretion through aldosterone-stimulated increased H ϩ -ATPase activity. The increased aldosterone in this setting is mediated through endothelin, which itself increases distal nephron Na ϩ /H ϩ exchange. The data support that aldosterone and endothelins are important mediators of the increased distal nephron acidification associated with increased intake of dietary protein, the common dietary challenge to systemic acid-base homeostasis faced by humans.
